TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 37 filers reported holding TERNS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $648,991 | -42.2% | 129,024 | +0.5% | 0.00% | – |
| Q2 2023 | $1,123,308 | +365.3% | 128,378 | +529.7% | 0.00% | – |
| Q1 2023 | $241,394 | +115.5% | 20,388 | -46.4% | 0.00% | – |
| Q1 2022 | $112,000 | -55.7% | 38,059 | +6.6% | 0.00% | – |
| Q4 2021 | $253,000 | -11.8% | 35,700 | +29.8% | 0.00% | – |
| Q3 2021 | $287,000 | +0.3% | 27,513 | +18.2% | 0.00% | – |
| Q2 2021 | $286,000 | -32.5% | 23,286 | +20.8% | 0.00% | – |
| Q1 2021 | $424,000 | – | 19,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |